Transcutaneous Energy Transfer

Transcutaneous energy transfer (TET) is the delivery of electrical power across intact skin to an implanted device, without any wire penetrating the body surface. Power crosses the skin barrier by magnetic induction between an external coil worn on the body and an internal coil implanted beneath the skin. By eliminating the percutaneous wire that would otherwise carry power inward, TET removes a chronic site of infection and mechanical failure, an advantage that becomes decisive for implants whose power demand is too large for a practical internal battery.

The technique is most closely associated with mechanical circulatory support, where ventricular assist devices draw continuous watts of power, but the same principles apply to a broad class of implants that benefit from contactless recharging or continuous powering. The engineering challenge is to transfer adequate power efficiently across a variable gap of living tissue while keeping tissue heating, electromagnetic exposure, and component temperature within safe bounds.

This article describes the inductive mechanism of transcutaneous transfer, the design of the coupled coils, the efficiency and thermal constraints that bound the achievable power, the tissue-safety considerations that govern exposure, the resonant techniques that improve tolerance to coil misalignment, the principal implant applications, and the comparison with the percutaneous leads that TET seeks to replace.

Principles of Inductive Transfer Through Skin

Magnetic Coupling Across the Barrier

Transcutaneous energy transfer relies on near-field magnetic induction. An alternating current in the external transmitting coil generates a time-varying magnetic field, a portion of which threads the implanted receiving coil and induces a voltage there. The skin and subcutaneous tissue between the coils are essentially transparent to the magnetic field at the frequencies used, so the field couples through the barrier without requiring any conductive path. The implanted coil feeds a rectifier and regulator that supply the device and, in most systems, charge an internal backup battery.

The Coupling Coefficient

The fraction of the transmitter's magnetic flux that links the receiver is captured by the coupling coefficient, a dimensionless number between zero and one. A separation of several millimeters to a centimeter or more of tissue, combined with the modest coil diameters that comfort and anatomy permit, yields a loosely coupled link whose coupling coefficient is well below unity. Loose coupling is the defining condition of transcutaneous transfer and shapes nearly every design decision, because much of the transmitted flux returns to the source without reaching the receiver.

Operating Frequency Selection

The choice of operating frequency balances competing effects. A higher frequency raises the voltage induced for a given coil and field, easing the transfer of power across a loosely coupled link, and it permits smaller coils. A higher frequency, however, increases losses in the coil conductors and in surrounding tissue and raises the rate at which tissue absorbs electromagnetic energy. Practical transcutaneous systems therefore operate in a band, broadly from the low hundreds of kilohertz to a few megahertz, that secures useful coupling while keeping tissue absorption and conductor losses manageable. Reported systems commonly sit between roughly one hundred kilohertz and a couple of megahertz.

Coil Design and Coupling

Geometry and Alignment

Coil geometry sets the coupling that the link can achieve. Larger-diameter coils capture more mutual flux and tolerate greater separation, but the implanted coil's size is constrained by the anatomy of the implant pocket and by patient comfort. Coaxial alignment of the two coils maximizes coupling, yet the external coil, held against the skin by a garment or adhesive, inevitably shifts laterally and angularly during daily activity. Designers therefore optimize coil diameter and spacing to sustain adequate coupling across the realistic range of displacement rather than only at perfect alignment.

Conductor and Quality Factor

Because the link is loosely coupled, the quality factor of each coil strongly influences how much power reaches the load. High quality factor requires low conductor loss at the operating frequency, which is commonly achieved with litz wire whose many fine, individually insulated strands reduce the skin-effect and proximity-effect resistance that solid conductors would suffer. The implanted coil must additionally use biocompatible materials and a hermetic or biostable construction suited to permanent residence in the body.

Flux Guidance and Shielding

Some designs incorporate high-permeability magnetic material to guide flux toward the receiving coil and to shield nearby tissue and electronics from stray field. Any such material must be chosen for compatibility with the implant environment and for low loss at the operating frequency, since lossy magnetic material would itself heat. Conductive structures near the coils, including the metallic housing of the implant, perturb the field and induce eddy-current losses that the coil layout must account for.

Efficiency and Thermal Limits

Sources of Loss

End-to-end efficiency is the product of the efficiencies of the transmitter electronics, the coupled-coil link, and the receiver rectification and regulation. The coupled link is typically the limiting stage in a loosely coupled system, because flux that fails to link the receiver represents energy that circulates in the transmitter and dissipates in its resistance. The link efficiency a loosely coupled pair can reach is bounded by the product of the coupling coefficient and the coil quality factors, and well-designed resonant transcutaneous links commonly target coil-to-coil efficiencies above eighty percent, though the overall figure from source to load is lower once the transmitter and receiver electronics are included. Additional loss arises in the coil conductors, in any magnetic material, and through eddy currents induced in nearby conductive tissue and hardware.

The Thermal Constraint

The dissipated power that does not reach the load appears as heat, and in an implant that heat must be shed into surrounding tissue. Tissue tolerates only a modest temperature rise before cellular function is impaired, which places a hard ceiling on the loss that an implanted receiver and coil may dissipate. This thermal limit, rather than any electrical limit, frequently bounds the power a transcutaneous system can deliver, and it is the reason efficiency is pursued as a safety requirement and not merely as an energy-conservation goal.

Managing Implant Temperature

Designers manage implant temperature by maximizing link efficiency, by spreading any unavoidable dissipation across a larger surface to lower local heat flux, and by siting heat-generating electronics where blood flow aids cooling. The external transmitter, freed from the tissue thermal limit, can dissipate more heat and can be cooled conventionally, so loss is preferentially shifted to the external side of the link wherever the system architecture allows.

Tissue Safety and Specific Absorption Rate

Field Exposure and Absorption

The alternating magnetic field and the associated electric field deposit energy in tissue, and the resulting heating is quantified by the specific absorption rate, the power absorbed per unit mass of tissue, expressed in watts per kilogram. Above roughly one hundred kilohertz, tissue heating rather than nerve stimulation is the dominant biological effect, so specific absorption rate is the governing exposure metric across the frequencies transcutaneous systems use. Regulatory and consensus exposure limits, such as those issued by the International Commission on Non-Ionizing Radiation Protection and the corresponding IEEE standard, cap the specific absorption rate to prevent harmful tissue heating, and a transcutaneous system must keep both localized and whole-body absorption within these limits across its operating range. Because absorption rises with frequency, the specific absorption rate constraint reinforces the frequency choices discussed above.

Thermal Safety Margins

Beyond field absorption, direct conductive heating from the coils and electronics contributes to the total thermal load on tissue. Safe design treats the combined effect, keeping the steady-state temperature rise of skin and underlying tissue within bounds recognized to avoid injury, with margin for worst-case conditions such as poor coil alignment that increases transmitter current and stray field. Sustained operation rather than brief exposure governs the limit, because an implant powers a device continuously.

Electromagnetic Compatibility and Biological Effects

A transcutaneous link must neither interfere with nor be disrupted by other medical electronics, and it must not couple hazardous energy into co-located implanted leads or sensing circuits. The field strengths involved are evaluated against established guidance on human exposure to electromagnetic fields, and the system is designed so that foreseeable faults do not expose tissue to field levels or temperatures beyond the safe range.

Resonant Links

Compensating the Coil Reactance

Each coil presents a large inductive reactance at the operating frequency, and a loosely coupled pair of bare coils transfers power poorly. Adding a capacitor to resonate with each coil at the operating frequency cancels the reactance, allowing large currents to circulate for a modest driving voltage and sharply increasing the power delivered across the gap. Resonant compensation is therefore standard in transcutaneous systems, applied on the transmitter side, the receiver side, or both.

Tolerance to Misalignment and Distance

Resonant operation also improves the link's tolerance to the changing geometry of a worn external coil. A well-designed resonant link sustains useful power transfer across a range of separations and lateral offsets where a non-resonant link would collapse. This robustness directly addresses the central practical difficulty of transcutaneous transfer, namely that the coupling coefficient varies continuously as the patient moves.

Tuning, Detuning, and Control

The resonant frequency depends on coil inductance and on the compensating capacitance, both of which can drift with temperature, with the proximity of conductive tissue and hardware, and with coil displacement. Systems accommodate this drift through adaptive control that adjusts the drive frequency or the transmitter operating point to track resonance, and through feedback from the implant that reports received voltage so the transmitter can deliver only the power the implant currently needs. Such closed-loop regulation maintains efficiency and prevents over-delivery of power as conditions change.

Powering Implants

Ventricular Assist Devices

Mechanical circulatory support is the application that most demands transcutaneous transfer. A ventricular assist device drives a blood pump continuously and requires on the order of several watts, typically a few watts on average with higher transient peaks, far more than an implantable battery could supply for a useful interval. Such devices have historically drawn power through a percutaneous driveline, a wire emerging through the skin, which is reliable but introduces a permanent infection risk at the exit site. Transcutaneous energy transfer aims to power the pump and recharge an internal backup battery across intact skin, removing the driveline and its infection burden while retaining a battery reserve to bridge interruptions of the external link. No transcutaneous system has yet achieved durable, fully implanted clinical use for circulatory support, and the driveline remains the standard means of powering these devices, so transcutaneous transfer for this application is an active goal rather than established practice.

Rechargeable Implant Recharging

A broad class of rechargeable implants, including certain neurostimulators and other therapeutic devices, uses transcutaneous transfer not for continuous powering but for periodic recharging of an internal battery. The patient applies the external coil for a recharge session lasting from minutes to a few hours, after which the implant runs from its battery until the next session. This intermittent use relaxes the continuous thermal constraint somewhat but still requires that recharge-session heating remain within safe limits.

Low-Power and Battery-Free Implants

Some implants draw little enough power that they can run directly from the inductive link whenever the external coil is present, dispensing with an internal battery altogether. Conventional pacemakers do not require transcutaneous powering, because their microwatt-level consumption is met for about a decade by a primary lithium cell; the relevance of inductive coupling to such devices lies historically in telemetry and, more recently, in research toward battery-free and rechargeable designs. Battery-free architectures suit implants that need not operate when the external unit is absent and that benefit from the smallest possible implanted volume.

Comparison With Percutaneous Leads

Infection and Mechanical Reliability

A percutaneous lead carries power inward through a permanent opening in the skin, and that opening never fully heals, providing a route for bacteria and a site of chronic irritation. Driveline infection is a leading source of complication in long-term circulatory support. The percutaneous wire is also subject to mechanical fatigue and damage where it crosses the skin and moves with the body. Transcutaneous transfer eliminates both hazards by carrying no conductor through the skin, which is its principal clinical motivation.

Efficiency, Reserve, and Convenience

The percutaneous lead transfers power with very high efficiency and imposes no tissue-heating limit, advantages that a loosely coupled inductive link cannot match. Transcutaneous systems therefore accept lower efficiency and a bounded power capability, and they incorporate an implanted backup battery to sustain the device when the external coil is removed, for instance during bathing or while sleeping. The patient must wear and maintain the external transmitter and keep it reasonably aligned, a burden the percutaneous approach avoids.

Engineering Trade-Off

The comparison reduces to a trade between a wire that is efficient but breaches the skin and a field that preserves the skin but transfers power less efficiently and with thermal limits. For high-power, long-duration implants, the infection and reliability advantages of an intact skin barrier increasingly justify the added complexity and the efficiency penalty of transcutaneous transfer, while lower-power implants may favor either approach depending on their power budget and required runtime.

Summary

Transcutaneous energy transfer delivers power to implants by magnetic induction across intact skin, replacing the infection-prone percutaneous wire. Loose coupling between an external and an implanted coil governs the design: coils are sized and tuned to sustain coupling despite the constant misalignment of a worn transmitter, resonant compensation raises and stabilizes the transferred power, and efficiency is pursued because every watt of loss in the implant must be shed as heat into tissue that tolerates only a small temperature rise. Specific absorption rate and thermal limits cap the deliverable power and shape the frequency choice. The technique is central to ventricular assist devices and to rechargeable implants, where the clinical benefit of an unbroken skin barrier outweighs the efficiency and convenience advantages that percutaneous leads retain.

Electronics Guide